MIT researchers found a way to measure cell density quickly and accurately -- measuring up to 30,000 cells in a single hour.

Finance Income, net was $1.0 million for the three months ended March 31, 2025, compared to $0.7 million in the same period ...

In recent years, the therapeutic landscape for hematological malignancies has undergone a profound transformation, driven by ...

Scientists have created a new type of super-strong antibody that could significantly enhance cancer immunotherapy. In an ...

Chikungunya virus (CHIKV) is a mosquito-borne pathogen that has been identified in more than 110 countries around the world. The virus typically causes flu-like symptoms, but it can also trigger ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

By studying Chikungunya virus, scientists shed light on how immune responses to viral infections may lead to persistent symptoms of autoimmune disease.

A new study published in Nature Cancer reveals that age-related metabolic decline impairs the efficacy of CAR-T cell therapy.

Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools.